Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Bills Unveiled: Does Provider Reimbursement Take Precedence?

Executive Summary

The slim prospects for enactment of a Medicare outpatient prescription drug benefit have legislators eyeing the $350 bil. House budget set-aside as a source of enhanced provider reimbursements in 2002

You may also be interested in...



Rx Pricing Attacks Fail In Key House Races; Medicare Rx Vote Protects GOP

The House leadership is unlikely to change its approach to Medicare prescription drug coverage and pharmaceutical pricing following the Republican victories in the mid-term elections Nov. 5

Rx Pricing Attacks Fail In Key House Races; Medicare Rx Vote Protects GOP

The House leadership is unlikely to change its approach to Medicare prescription drug coverage and pharmaceutical pricing following the Republican victories in the mid-term elections Nov. 5

PBM Quality Comparisons Feature In Senate Dems’ Medicare Rx Bill

PBMs delivering a drug benefit under Medicare would be subject to quality and consumer satisfaction comparisons under Sen. Bob Graham's (D-Fla.) Medicare Rx bill

Related Content

UsernamePublicRestriction

Register

LL1121650

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel